![Dr. Eric Hutton Raabe M.D., Hematologist (Pediatric)](/doctor_images/6/61/1847025.jpg?v=da18)
Dr. Eric Hutton Raabe M.D.
Hematologist (Pediatric) | Pediatric Hematology-Oncology
600 N Wolfe St Pediatric Oncology C Baltimore MD, 21287About
Dr. Eric Raabe is a pediatric hematologist practicing in Baltimore, MD. Dr. Raabe specializes in treating children that have a blood disease or cancer. Such blood diseases include disorders of red blood cells, white blood cells and/or platelets. The types of cancers that Dr. Raabe treats include leukemias, lymphomas and certain tumors. Dr. Raabe can also treat bleeding disorders in children. Pediatric hematologists can be found in childrens hospitals, community hospitals, university medical centers and more.
Education and Training
University of Cincinnati / Main Campus 1999
University of Cincinnati College of Medicine 2003
Board Certification
PediatricsAmerican Board of PediatricsABP- Pediatric Hematology-Oncology
DermatologyAmerican Board of DermatologyABD- 2011
PediatricsAmerican Board of PediatricsABP- 2008
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Proliferation-associated SNF2-like gene (PASG): a SNF2 family member altered in leukemia.
- An SNF2 factor involved in mammalian development and cellular proliferation.
- Growth retardation and premature aging phenotypes in mice with disruption of the SNF2-like gene, PASG.
- LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program.
- mTOR: a new therapeutic target for pediatric low-grade glioma?
- The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity.
- Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target.
- Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.
- Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances
- Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.
- Diffusion tensor imaging suggests extrapontine extension of pediatric diffuse intrinsic pontine gliomas.
- DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets.
- The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma.
- The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma.
- The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to
Treatments
- Brain Cancer, Cancer
- Brain Tumor
- Leukemia
- Dermal Aesthetics
- Extra Corporeal Shockwave Therapy
Fellowships
- National Institutes of Health - Credentialing Services Section/Pediatric Oncology 2011
- The Johns Hopkins Hospital/Pediatric Oncology 2011
Dr. Eric Hutton Raabe M.D.'s Practice location
Eric Raabe
600 N Wolfe St Pediatric Oncology C -Baltimore, MD 21287Get Direction
Dr. Eric Hutton Raabe M.D.'s reviews
Write ReviewRecommended Articles
- An Innovative Method for the Early Prediction of Parkinson's Disease
As technology advances, so does the methods at the researcher’s disposal to create innovative tools that can be used in many contexts to, in one way or another, improve the user’s effectiveness at performing certain tasks. Case in point, a team of researchers from the Washington University...
- Is Caffeine Okay to Consume with Colitis?
In the United States alone, more than 1 million individuals suffer from an inflammatory bowel disease (IBD) such as ulcerative colitis and Crohn’s disease. Such diseases interfere with the body’s ability to absorb the nutrients it requires, thereby leading to deficiencies. If you are suffering...
- Purpura
PurpuraPurpura refers to purple-colored spots that are usually seen on the skin, including mucous membranes and other organs. It is also called skin hemorrhages or blood spots.Purpura is usually recognized when there is pooling of blood under the skin due to ruptured small blood vessels. The size of...
- Potential Causes of Leukopenia
IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
- Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients
Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
- How Is Leukemia Diagnosed?
Leukemia in its early stages may present no signs or symptoms, as these only appear when the leukemia cells have taken over a large number of normal blood cells. A person with leukemia is very lucky indeed if early-stage detection occurs incidentally, through a routine blood test or one done for...
Nearby Providers
- Dr. Christopher Jordan Gamper M.D., PH.D.601 N Caroline St Baltimore MD 21287
- Dr. Suzie A Noronha M.D.Johns Hopkins Hospital Baltimore MD 21287
- Dr. Rachel E Rau MD800 Johns Hopkins Hospital Cmsc Baltimore MD 21287
- Dr. Stephanie O Omokaro M.D.600 N Wolfe St Baltimore MD 21287
- Dr. James Taylor M.D.1800 Orleans St Baltimore MD 21287
- Dr. Catherine Michelle Albert MD600 N Wolfe St Baltimore MD 21287
Nearest Hospitals
KENNEDY KREIGER INSTITUTEl
707 NORTH BROADWAY BALTIMORE MD 21205